-
Haisco: Phase III clinical trial of cyclopofol injection received ethical approval
Time of Update: 2021-08-16
On July 7th, Haisco announced that the Phase III clinical trial of the innovative drug cyclopofol injection has been ethically approved .
-
Jazz oncology drug Rylaze is approved by FDA for treatment of ALL and LBL
Time of Update: 2021-08-16
CompileriverA few days ago, Rylaze, an oncology drug from Jazz Pharmaceuticals, was approved by the US FDA for the treatment of pediatric patients 1 month and older who are allergic to E.
-
What is the largest increase in Hengrui, Shanghai Pharmaceuticals, CSPC, and Yangtze River's impact on the top 20 global pharmaceutical companies?
Time of Update: 2021-08-16
Generally speaking, there are two paths: after the innovative drug is listed in the mainstream market, it becomes a blockbuster with annual revenue of over US$1 billion; or it "subverts" Hengrui's past development genes and completes a major acquisition .
-
In the first half of the year, 36 pharmaceutical companies got together and listed on the market, and the financing of innovative drugs ushered in a climax?
Time of Update: 2021-08-16
At the same time, the total IPO funds raised by 22 medical device companies in the two markets exceeded 24 billion yuan in the first half of the year .
-
The Gains and Losses of Separation of Medicine from Japan
Time of Update: 2021-08-16
Therefore, the stagnation of the prescription drug market in Japan after 2015 is due to the replacement strategy of generic drugs, which means that as long as the payment policy is adjusted at the drug sales terminal, the total drug cost can be effectively controlled, which was promoted by the previous large-scale redemption policy.
-
Jiangsu Wuzhong YS001 Capsule was approved to carry out clinical trials for the treatment of advanced malignant solid tumors
Time of Update: 2021-08-16
YS001 capsule is a PI3K/mTOR dual-target inhibitor independently developed by Suzhou Zerun New Drug R&D Co.
The target indications for its research and development are advanced malignant solid tumors such as breast cancer, kidney cancer, gastric cancer, and ovarian cancer .
-
The world's first 14-valent HPV vaccine! Shenzhou cell SCT1000 enters the clinic
Time of Update: 2021-08-16
Recently, Shenzhou Cell announced that its self-developed 14-valent HPV vaccine SCT1000 has entered clinical phase I/II studies and completed the enrollment of all 80 subjects .
It is worth noting that this is the world's first 14-valent HPV vaccine to enter the clinical research phase .
-
A giant pharmacy store will break 10,000
Time of Update: 2021-08-16
In 2020, the common people's pharmacy told the media that in the next three years, the company will maintain a growth rate of about 2,000 new stores each year, including directly-operated stores, franchised stores, and mergers and acquisitions stores .
-
Subcutaneous injection of PD-L1 antibody envolimab was again approved as an orphan drug by the U.S. FDA
Time of Update: 2021-08-16
Corning Jereh announced that the company's self-developed recombinant humanized PD-L1 single domain antibody envolimab injection has been granted orphan drug designation by the US Food and Drug Administration for the treatment of soft tissue sarcoma .
-
13 injections are included!
Time of Update: 2021-08-16
▌ Winning rules and winning price▌ Winning rules and winning priceAccording to the announcement of the Jiangsu Medical Insurance Bureau, considering the attributes of drugs, the characteristics of clinical use in Jiangsu Province and the guarantee of supply, and according to the characteristics of different groups and market structure, the selected companies shall be determined by negotiation or bidding respectively: the total number of companies in Group A and Group B is different.
-
154 million!
Time of Update: 2021-08-16
On February 5 of the same year, Yixintang issued an announcement stating that its wholly-owned subsidiary, Shanxi Yixintang, planned to acquire 29 store assets held by Shanxi Baixing Pharmaceutical Chain Co.
-
FDA releases Biogen Alzheimer's disease new drug review memorandum
Time of Update: 2021-08-16
Peter Stein, director of the Office of New Drugs, and the memorandum signed by Dr.
According to the data, CDER Director Patrizia Cavazzoni and Director of the Office of New Drugs Peter Stein both agreed with the accelerated approval proposed by Billy Dunn, head of FDA neuroscience, while the staff of the FDA Office of Biostatistics believed that approval was unnecessary .
-
Hunan Provincial Public Resources Trading Center issued an announcement on the price adjustment of some drugs on the Internet
Time of Update: 2021-08-16
The content of the announcement pointed out that, in accordance with the "Notice of the Hunan Provincial Public Resource Exchange Center of the Hunan Provincial Medical Security Bureau on Regulating the Purchasing of Drugs on the Internet", the price of some drugs on the Internet that enterprises apply to be adjusted is now publicized .
-
Luoxin Pharmaceutical: Lansoprazole for injection passed the consistency evaluation of generic drugs
Time of Update: 2021-08-16
According to IQVIA data, the global sales of lansoprazole for injection in 2020 will be 210 million U.
S. dollars (calculated at the ex-factory price), and the domestic sales amount in China will be 1.
-
Current status of research and development of neuropathic pain drugs
Time of Update: 2021-08-16
Recently, the literature reported that the target KCNQ2/3/5 (Kv7) channel opener retigabine (RTG) can significantly reduce Neuronal excitability, and effective in a variety of pain models, the two-hole potassium channel subtype TREK1 (TWIK-related K+ channel 1) is the key target of morphine analgesia without opioid adverse reactions, which provides new opportunities for neuropathic pain Treatment strategies .
-
A group of giant pharmacies participate in online medical insurance purchases
Time of Update: 2021-08-16
Buy medicines online to get medical insurance, Shenyang officially pilotsBuy medicines online to get medical insurance, Shenyang officially pilotsAccording to Shenyang's public account report, on July 5, the first batch of 62 pilot designated pharmacies in Shenyang officially opened medical insurance payment on the Meituan platform, and citizens can enjoy the convenient drug purchase service of "order online, medical insurance payment, and delivery of medicines to home" .
-
After Aducanumab was approved, the development of new drugs for Alzheimer's disease is surging
Time of Update: 2021-08-16
Text | Pickup BayOn June 7, the FDA accelerated the approval of Biogen/Eisai’s Aβ (amyloid β) antibody Aduhelm (aducanumab) for the treatment of Alzheimer’s disease (AD) patients with a biological product license (BLA) based on the biomarker surrogate endpoint.
-
Five people detained for selling aphrodisiac drugs in pharmacies
Time of Update: 2021-08-16
It was identified that the 9 types of sexual health products involved in the case contained toxic and harmful non-food ingredients "sildenafil" or "tadalafil" and other ingredients that are expressly prohibited from being added, and none of them were produced by the relevant company or applied the approval number of the company.
-
Tonghua Dongbao: Dongbao Zixing three-target inhibitor product obtained clinical approval
Time of Update: 2021-08-16
On June 28, Tonghua Dongbao announced that its three-target inhibitor product (THDBH101 capsule/WXSHC071 capsule) has been approved for clinical application.
As of the date of this announcement, the company has invested approximately RMB 25.
27 million in research and development expenses in this project .
-
Beida Pharmaceuticals BPI-23314 drug clinical trial application accepted
Time of Update: 2021-08-16
On the 29th, Betta Pharmaceuticals announced that it received the "Notice of Acceptance" issued by the NMPA, and the company declared BPI-23314 tablets for the treatment of malignant hematological tumors (including but not limited to myelofibrosis and other myeloproliferative tumors and myelodysplastic syndromes.
